Glioblastoma, Glioma, Malignant
Conditions
Keywords
glioma stem-like cells, brain organoids, brain invasion, ciliogenesis
Brief summary
In patients operated for glioblastoma, glioma stem-like cell lines will be obtained from tumor tissue, and IPSCs from skin fibroblasts or PBMCs. Brain organoids will be generated from IPSCs and co-cultured with IPSCs to study brain invasion and ciliogenesis. 3D genome architecture of glioma stem-like cells will be investigated. Gene modulation and pharmacologic strategies to inhibit invasion and restore ciliogenesis will be explored.
Interventions
Collection of biological samples
Sponsors
Study design
Eligibility
Inclusion criteria
o be enrolled in the study patients must: 1. Have a radiological diagnosis of supratentorial glioblastoma, or 2. Have a radiological diagnosis of first recurrence of a primary supratentorial glioblastoma (for which a formal histopathologic diagnosis of glioblastoma had made at first surgery), according with RANO criteria (Wen, 2010); 3. Be a candidate to neurosurgery for glioblastoma; 4. Be of an age of 18 years or above; 5. Provide written informed consent for participation to the study.
Exclusion criteria
To be enrolled in the study patients must not: 1. Have not enough pathological material removed at surgery available both for mandatory routine histopathological diagnosis and for the present study, as judged by the Principal Investigator; 2. Have not a definitive pathological diagnosis of a primary supratentorial glioblastoma, according with 2016 WHO classification.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Invasion | through study completion, an average of 4 years | Distance travelled by glioma stem cells into brain organoids |
| Gene assessment | through study completion, an average of 4 years | Identification of genes responsible of GSC invasion, among those reportedly involved in self-renewal and ciliogenesis |
Countries
Italy